Imfinzi (durvalumab) - AstraZeneca
Andewei (benmelstobart) - Apollomics, Sino Biopharm
DLL3-CAR-NK cells - Tianjin Medical University Cancer Institute and Hospital
Tecentriq (atezolizumab) - Roche
carboplatin - Generic mfg.
Hetronifly (serplulimab) - Fosun Pharma
etoposide IV - Generic mfg.
Focus V (anlotinib) - Advenchen, Sino Biopharm
cisplatin - Generic mfg.
Xpovio (selinexor) - Karyopharm
Tevimbra (tislelizumab-jsgr) - BeOne Medicines
Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Biosci, Coherus Oncology
http://clinicaltrials.gov/ct2/show/NCT07172412
 
Sep 16, 2025
 
Next